secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001641489-25-000016
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics posts updated March 2025 investor presentation; specific content not available for review
--------------------------------------------------------------------------------

- Filing is a Reg FD disclosure of a slide deck used for meetings with investors and analysts.
- Deck titled 'Improving the Lives of Millions of People Living with Type 1 Diabetes'.
- No financial results, pipeline data, or material updates can be extracted from the provided excerpt.
- Full presentation content was not included in the filing text; confidence in summarizing news is low.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148925000016/0001641489-25-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148925000016/vtvt-20250331.htm
  HTML page:      https://secwatch.observer/filing/0001641489-25-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer